Regarding inflammatory-related indicators, albumin levels in the cancer group (4.19 ± 0.33 g/dL) demonstrated significantly reduced levels relative to the non-cancer group (4.33 ± 0.33 g/dL) (P < 0.001). This evidence concerns the gene ALB and cancer.